Evidence map›Paper›PMID 42131247›Full record

ArticleCureus2026

Recurrent Takotsubo Syndrome and Pulmonary Embolism Revealing a Pheochromocytoma: A Diagnostic Pitfall.

Alfakihi Ahmed Said IsmaIl, Jonathan Moyambi, Salim Arous, Abdenasser Drighil, Brahim Meftout

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alfakihi Ahmed Said IsmaIlCardiology, CHU Ibn Rochd, Casablanca, MAR.
Jonathan MoyambiCardiovascular Disease, CHU Ibn Rochd, Casablanca, MAR.
Salim ArousCardiology, CHU Ibn Rochd, Casablanca, MAR.
Abdenasser DrighilCardiology, CHU Ibn Rochd, Casablanca, MAR.
Brahim MeftoutCardiology, Centre Hospitalier Sud Francilien, Corbeil-Essonnes, FRA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stress cardiomyopathy (Takotsubo syndrome or TTS) is an acute and reversible left ventricular dysfunction typically triggered by emotional or physical stress. Although most cases are idiopathic, secondary causes should be suspected in cases of recurrence, unusual severity, or atypical presentation. The association between TTS and pulmonary embolism (PE) is rare and may lead to diagnostic pitfalls, particularly when left ventricular dysfunction is misinterpreted as a marker of embolic severity. We report the case of a 46-year-old woman with two episodes of TTS one year apart. The second episode, presenting as a reverse Takotsubo pattern, was complicated by cardiogenic shock and multiorgan failure. A thoraco-abdominopelvic CT scan performed during etiological workup revealed a subsegmental PE without right ventricular dysfunction. The diagnosis of TTS was confirmed by ventriculography, demonstrating characteristic wall motion abnormalities in the absence of obstructive coronary artery disease. The diagnosis of pheochromocytoma was established based on concordant imaging findings (abdominal CT and positron emission tomography revealing an adrenal mass) and biochemical confirmation with markedly elevated plasma and urinary metanephrine levels. This case highlights the importance of investigating secondary causes in recurrent or atypical TTS and emphasizes that, in the setting of PE associated with left ventricular dysfunction, concomitant cardiomyopathy should be considered rather than attributing findings solely to embolic severity.

Indexed as

cardiogenic shockleft ventricular dysfunctionmultimodal imagingpheochromocytomapulmonary embolismstress cardiomyopathy

Identifiers

PMID42131247
PMCPMC13166324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.